Schering-Plough Names Baxter’s Sabatino As General Counsel
Schering-Plough has selected former Baxter exec Thomas Sabatino to be its general counsel as the company works to resolve investigations into marketing and pricing practices
You may also be interested in...
A criminal investigation of Schering-Plough's marketing practices includes off-label promotion, the company disclosed May 30
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials